- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Precious Metals
U.S. Pharmaceuticals & Biotech Precious Metals
Results
136
0 new
Gold, Silver and Precious Metals companies ordered by Snowflake size.
136 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VNDA | US$4.74 | 1.9% | 8.7% | US$282.7m | US$8.07 | PS1.5x | E79.7% | n/a | ||
SLNO | US$48.77 | -7.5% | 76.8% | US$1.9b | US$70.29 | PB6.8x | E68.2% | n/a | ||
RCEL | US$10.58 | -2.3% | -27.4% | US$272.9m | US$15.65 | PS5.1x | E69.6% | n/a | ||
CLRB | US$1.91 | -9.5% | -24.8% | US$68.8m | US$16.33 | PB7.5x | E67.7% | n/a | ||
CDXC | US$3.78 | 2.2% | 168.1% | US$287.7m | US$6.54 | PS3.4x | E102.9% | n/a | ||
ARQT | US$9.16 | -9.7% | 65.3% | US$1.1b | US$18.57 | PS8.1x | E69.3% | n/a | ||
BFRI | US$1.26 | -1.6% | -85.6% | US$6.9m | US$11.50 | PB0.6x | E70.6% | n/a | ||
BLTE | US$46.85 | -3.5% | 47.1% | US$1.4b | US$56.75 | PB12.5x | E65.5% | n/a | ||
EBS | US$7.28 | 4.1% | 119.9% | US$320.9m | US$8.00 | PB1x | E106.4% | n/a | ||
PTN | US$0.95 | -26.6% | -36.8% | US$18.6m | US$11.50 | PS3.1x | E84.6% | n/a | ||
CYBN | US$9.88 | 15.4% | -46.8% | US$210.4m | US$158.99 | PB1x | E58.7% | n/a | ||
ITCI | US$73.21 | -4.9% | 36.1% | US$7.9b | US$96.13 | PS13.7x | E64.4% | n/a | ||
SPRC | US$0.24 | -13.7% | -93.6% | US$806.7k | n/a | PB0.1x | E62.1% | n/a | ||
VCYT | US$33.51 | -4.9% | 46.3% | US$2.6b | US$33.50 | PS6.4x | E108.1% | n/a | ||
SCYX | US$1.51 | -7.4% | -34.3% | US$57.2m | US$6.67 | PS5.9x | E49.4% | n/a | ||
DARE | US$3.26 | -3.1% | -42.3% | US$28.2m | US$21.33 | PS9.8x | E61.0% | n/a | ||
KALV | US$10.00 | -9.1% | 3.5% | US$408.8m | US$29.20 | PB2.5x | E60.3% | n/a | ||
APVO | US$0.18 | 2.3% | -98.7% | US$2.4m | US$8.00 | PB0.5x | E59.7% | n/a | ||
CAPR | US$9.99 | 100.2% | 71.8% | US$365.4m | US$31.00 | PS13x | E68.7% | n/a | ||
RNXT | US$1.04 | 5.2% | -20.4% | US$25.2m | US$5.25 | PB2.7x | E63.9% | n/a | ||
SWTX | US$32.29 | -8.7% | 37.6% | US$2.4b | US$68.13 | PS27.8x | E75.6% | n/a | ||
AXSM | US$89.64 | -5.0% | 22.7% | US$4.3b | US$125.24 | PS14.8x | E68.9% | n/a | ||
ZVRA | US$7.31 | -8.9% | 47.5% | US$397.0m | US$20.50 | PS16.2x | E68.5% | n/a | ||
MDGL | US$213.90 | -11.7% | 41.0% | US$4.7b | US$360.57 | PS317.3x | E68.1% | n/a |